AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2017
Sep 26, 2017
30237_dirs_2017-09-26_0026a4f4-c83a-4d80-8e42-4754bed1aa85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-09-25
Reporting Person: Caveney Brian J (SVP, Chief Medical Officer)
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30